3375 Scott Boulevard
CBT Pharma is an emerging life sciences oncology company focused on developing innovative medicines targeting the growth and proliferation of cancer cells for which available treatments are inadequate.
The company was founded in 2016 with headquarters in California with global partners and a subsidiary in Asia. Our pipeline is comprised of four development-stage assets – an oral agent that specifically targets cancer metastasis, a pre-clinical candidate that targets uncontrolled growth signaling pathways, and two investigational products that restore the body’s immune system to recognize and kill cancer cells.
Founders: Feng Zhang, Jennifer Doudna, George Church, J. Keith Joung, and David Liu
CEO: Sanjeev Redkar, PhD, MBA
Executive Vice President and COO: Gavin Choy, PharmD, MBA
Head of Business Development and Clinical Development: Uwe Peukert, MD, PhD, MBA
Please click here for CBT Pharma's Pipeline.